Memorandum of Understanding Between the United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University

---
identifier: "/us/fr/E9-31195"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Memorandum of Understanding Between the United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University"
title_number: 0
title_name: "Federal Register"
section_number: "E9-31195"
section_name: "Memorandum of Understanding Between the United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University"
positive_law: false
currency: "2010-01-05"
last_updated: "2010-01-05"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-31195"
document_type: "notice"
publication_date: "2010-01-05"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "75 FR 386"
fr_volume: 75
docket_ids:
  - "Docket No. FDA-2009-N-0667"
  - "FDA 225-09-007"
effective_date: "2009-11-19"
fr_action: "Notice."
---


#  Memorandum of Understanding Between the United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Northeastern University

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is providing notice of a Memorandum of Understanding (MOU) between FDA and Northeastern University. The purpose of the MOU is to form a collaborative relationship between FDA and Northeastern University; provide opportunities for exchanging of graduate and undergraduate students, faculty, and personnel and for advanced training and outreach; stimulate cooperative research, and information exchange in biological product characterization and regulation with Northeastern University's Barnett Institute of Chemical and Biological Analysis; and develop training programs for FDA and potentially other Government agencies and Industry in the broad areas of biotechnology and analytical chemistry.

**DATES:**

The agreement became effective November 19, 2009.

**FOR FURTHER INFORMATION CONTACT:**

Keith O. Webber, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20903, 301-796-2400, e-mail: *[email protected]* .

**SUPPLEMENTARY INFORMATION:**

In accordance with 21 CFR 20.108(c), which states that all written agreements and MOUs between FDA and others shall be published in the *Federal Register* , the agency is publishing notice of this MOU.

Dated: December 17, 2009.

David Dorsey,

Acting Deputy Commissioner for Policy, Planning and Budget.